Dr. Daniel Schraivogel works as a research staff scientist in the laboratory of Dr. Lars Steinmetz at the European Molecular Biology Laboratory (EMBL). He develops and applies novel technologies in the functional genomics space, by combining high-throughput CRISPR/Cas9 genetic screens with complex readouts from single cells. These technologies aim to provide a better understanding of genotype-phenotype correlations in health and disease by scaling with the complexity of the human genome. Prior to joining EMBL, Daniel did his PhD in the laboratory of Prof. Dr. Gunter Meister at the Max-Planck-Institute (MPI) of Biochemistry in Munich and Regensburg University, studying the function of short non-coding RNAs and their associated proteins.